Quillichew ER

Quillichew ER

CVS logo
CVS
$391.61
Albertsons logo
Albertsons
$373.75
Walgreens logo
Walgreens
$389.17
Walmart logo
Walmart
$394.43
Show this card to your pharmacist

Quillichew ER Savings card

$373.75

BIN
015995
ID
LHKXK432508
PCN
GDC
GRP
DR33

Print or send this coupon to your phone

About Quillichew ER

Drug Details

Methylphenidate is a medication prescribed for treating attention deficit hyperactivity disorder (ADHD). This stimulant drug works by altering the levels of certain natural chemicals in the brain, specifically norepinephrine and dopamine, and may also enhance serotonin activity. These changes help improve attention span, focus, and behavior management, aiding individuals in organizing tasks and enhancing listening skills. Methylphenidate is available in an extended-release (ER) form that is taken once daily, beginning to work within two hours and maintaining its effects throughout the day. As a controlled substance, it carries a risk of misuse and dependency and may cause side effects such as difficulty sleeping and reduced appetite. Always consult with a healthcare professional before starting any medication regimen.

Price history for Quillichew ER

30 Tablet Chewable Extended Releases, 20MG

Average retail price for Quillichew ER

Average SaveHealth price for Quillichew ER

Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.

*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.

Quillichew ER dosage forms

DosageQuantityPrice fromPer unit
20MG30 Tablet Chewable Extended Releases$373.95$12.47
20MG100 Tablet Chewable Extended Releases$1,206.85$12.07
30MG30 Tablet Chewable Extended Releases$373.48$12.45
30MG100 Tablet Chewable Extended Releases$1,205.27$12.05
40MG30 Tablet Chewable Extended Releases$372.93$12.43
40MG100 Tablet Chewable Extended Releases$1,203.43$12.03

Quillichew ER FAQs

QuilliChew ER is used for the treatment of attention deficit hyperactivity disorder (ADHD) in patients aged 6 years and older. It is a central nervous system stimulant that helps increase attention and decrease impulsiveness and hyperactivity in individuals with ADHD.

QuilliChew ER is approved for use in children aged 6 years and older for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). However, it is important for a healthcare provider to evaluate the child's health condition and medical history to determine if QuilliChew ER is appropriate and safe for them. Regular monitoring by a healthcare professional is recommended to assess the effectiveness and any potential side effects.

QuilliChew is not a narcotic. It is a central nervous system stimulant used to treat attention deficit hyperactivity disorder (ADHD).

QuilliChew, a medication used to treat ADHD in children, may cause several side effects. Common side effects include decreased appetite, trouble sleeping, stomach pain, irritability, and weight loss. Less common but more serious side effects can include increased heart rate, increased blood pressure, and mood changes such as aggression or mood swings. It's important for caregivers to monitor children for any side effects and consult a healthcare provider if they have concerns.

QuilliChew ER is an extended-release chewable tablet that is used to treat attention deficit hyperactivity disorder (ADHD) in individuals. It contains methylphenidate, which is a central nervous system stimulant. It can be effective in improving attention, focus, and impulse control in individuals with ADHD. However, its suitability and effectiveness can vary from person to person, and it should be prescribed and monitored by a healthcare professional.

Read All FAQs